These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 26424786)

  • 1. G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes.
    Wang XX; Edelstein MH; Gafter U; Qiu L; Luo Y; Dobrinskikh E; Lucia S; Adorini L; D'Agati VD; Levi J; Rosenberg A; Kopp JB; Gius DR; Saleem MA; Levi M
    J Am Soc Nephrol; 2016 May; 27(5):1362-78. PubMed ID: 26424786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
    Wang XX; Wang D; Luo Y; Myakala K; Dobrinskikh E; Rosenberg AZ; Levi J; Kopp JB; Field A; Hill A; Lucia S; Qiu L; Jiang T; Peng Y; Orlicky D; Garcia G; Herman-Edelstein M; D'Agati V; Henriksen K; Adorini L; Pruzanski M; Xie C; Krausz KW; Gonzalez FJ; Ranjit S; Dvornikov A; Gratton E; Levi M
    J Am Soc Nephrol; 2018 Jan; 29(1):118-137. PubMed ID: 29089371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGR5 activation suppressed S1P/S1P2 signaling and resisted high glucose-induced fibrosis in glomerular mesangial cells.
    Yang Z; Xiong F; Wang Y; Gong W; Huang J; Chen C; Liu P; Huang H
    Pharmacol Res; 2016 Sep; 111():226-236. PubMed ID: 27317945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice.
    Wang XX; Luo Y; Wang D; Adorini L; Pruzanski M; Dobrinskikh E; Levi M
    J Biol Chem; 2017 Jul; 292(29):12018-12024. PubMed ID: 28596381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice.
    Wang XX; Xie C; Libby AE; Ranjit S; Levi J; Myakala K; Bhasin K; Jones BA; Orlicky DJ; Takahashi S; Dvornikov A; Kleiner DE; Hewitt SM; Adorini L; Kopp JB; Krausz KW; Rosenberg A; McManaman JL; Robertson CE; Ir D; Frank DN; Luo Y; Gonzalez FJ; Gratton E; Levi M
    J Biol Chem; 2022 Nov; 298(11):102530. PubMed ID: 36209823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGR5 agonist INT-777 mitigates inflammatory response in human endometriotic stromal cells: A therapeutic implication for endometriosis.
    Lyu D; Tang N; Wang J; Zhang Y; Chang J; Liu Z; Liu H
    Int Immunopharmacol; 2019 Jun; 71():93-99. PubMed ID: 30878820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway.
    Kitada M; Kume S; Imaizumi N; Koya D
    Diabetes; 2011 Feb; 60(2):634-43. PubMed ID: 21270273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
    Lee HS; Suh JY; Kang BC; Lee E
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
    Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
    Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
    Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the bile acid receptor GPBAR1 (TGR5) ameliorates interleukin-1β (IL-1β)- induced chondrocytes senescence.
    Huang H; Lei H; Yang F; Fan X; Dang Q; Li Y
    Biomed Pharmacother; 2018 Oct; 106():1713-1719. PubMed ID: 30119246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons.
    Duboc H; Tolstanova G; Yuan PQ; Wu V; Kaji I; Biraud M; Akiba Y; Kaunitz J; Million M; Tache Y; Larauche M
    Neurogastroenterol Motil; 2016 Nov; 28(11):1663-1676. PubMed ID: 27259385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
    Donepudi AC; Boehme S; Li F; Chiang JY
    Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.
    Wang XX; Levi J; Luo Y; Myakala K; Herman-Edelstein M; Qiu L; Wang D; Peng Y; Grenz A; Lucia S; Dobrinskikh E; D'Agati VD; Koepsell H; Kopp JB; Rosenberg AZ; Levi M
    J Biol Chem; 2017 Mar; 292(13):5335-5348. PubMed ID: 28196866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid receptors and the kidney.
    Herman-Edelstein M; Weinstein T; Levi M
    Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):56-62. PubMed ID: 29045336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in mice.
    Eblimit Z; Thevananther S; Karpen SJ; Taegtmeyer H; Moore DD; Adorini L; Penny DJ; Desai MS
    Cardiovasc Ther; 2018 Oct; 36(5):e12462. PubMed ID: 30070769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in glomerular mesangial cells.
    Yang Z; Li J; Xiong F; Huang J; Chen C; Liu P; Huang H
    Exp Cell Res; 2016 Aug; 346(2):241-7. PubMed ID: 27292312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function.
    Comeglio P; Cellai I; Mello T; Filippi S; Maneschi E; Corcetto F; Corno C; Sarchielli E; Morelli A; Rapizzi E; Bani D; Guasti D; Vannelli GB; Galli A; Adorini L; Maggi M; Vignozzi L
    J Endocrinol; 2018 Aug; 238(2):107-127. PubMed ID: 29945982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy.
    Nangaku M; Izuhara Y; Usuda N; Inagi R; Shibata T; Sugiyama S; Kurokawa K; van Ypersele de Strihou C; Miyata T
    Nephrol Dial Transplant; 2005 Dec; 20(12):2661-9. PubMed ID: 16188903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.